Re: development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.
Unit for Clinical Research in Atherothrombosis, Centro Cardiologico Monzino IRCCS, Milan, Italy alessandro.parolari@cardiologicomonzino.it.
Alessandro
A
Parolari
Unit for the Study of Aortic, Valvular and Coronary Pathologies, Centro Cardiologico Monzino IRCCS, Milan, Italy.
Paola
P
Songia
Unit for Clinical Research in Atherothrombosis, Centro Cardiologico Monzino IRCCS, Milan, Italy.
Veronika
V
Myasoedova
Unit for the Study of Aortic, Valvular and Coronary Pathologies, Centro Cardiologico Monzino IRCCS, Milan, Italy.
Paolo
P
Poggio
D000818:Animals; D001705:Bioprosthesis; D006350:Heart Valve Prosthesis
Aortic valve development; Galactose-alpha-1,3-galactose; Valve durability; Xenograft